chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a physician via company representative refers to a 60 year old female patient. The patient had a medical history with Crohn's disease in the past prior to the vaccination. The patient's drug reactions or allergies were not reported. On an unknown date, the patient was vaccinated subcutaneously with ZOSTAVAX (dose, lot number and expiration date were not reported). Concomitant therapies included HUMIRA and prednisone (manufacturer unknown). On an unknown date, shortly after receiving the injection, the patient presented at a local hospital with unspecified symptoms and was admitted. She was diagnosed with Crohn's disease (date not reported). The outcome of the event was not reported. The relatedness between the event and the ZOSTAVAX was not reported. Additional information has been requested.
Mother of patient called on 8/16/2016 saying patient was at an outdoor event, standing in line waiting to purchase lemon aid, it was a hot afternoon. Patient fainted, she then attempted to get up and fainted again hitting her head on the lemon aid stand. Had no further problems after these two episodes of loss of consciousness.
After receiving the shingrix vaccine around 8:45 am Tuesday May 10, I developed an approximately one inch long  raised, red bumpy rash on right rear side of torso along bra line.  One Wednesday May 11 morning, an additional red raised bump had appeared on the front torso along bra line.  Both appeared to be shingles rash.  I went to see Nurse Practitioner at 1 pm on Wednesday May 11 to get checked out.  Although she could not definitively say it was shingles, due to the appearance of the rash and the timing of the rash coinciding with me receiving the shingrix vaccine, she decided the prudent course would be to treat it as if it were a shingles outbreak.  She prescribed one Aleve twice a day for 7 days, and 1 Valacyclovir 1g 3 times a day for 7 days.
Headache, Nausea, Stomach Ache.  Did not feel well enough to remain at school.  Parent contacted MD and advised to monitor.  Returned to school on 12/8/09.
Received MMR, DTaP, IPV, and upon leaving the office, had sneezing and nasal congestion. Ate part of a vanilla ice cream cone. Noticed eyes swelling shut and nose blocked. No pulmonary problems. Given Benadryl about 1 hour later then Nasonex. Returned to office; lungs clear, nose congested, eyes edematous. Received Benadryl every 6 hours for 24 hours and Nasonex QD for 3-4 days.
Caller also reported AE for herself that she contracted the COVID 19 virus after her primary series before getting the booster dose of Pfizer BioNtech covid 19 vaccine.; Caller also reported AE for herself that she contracted the COVID 19 virus after her primary series before getting the booster dose of Pfizer BioNtech covid 19 vaccine.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Caller also reported AE for herself that she contracted the COVID 19 virus after her primary series before getting the booster dose of Pfizer BioNtech covid 19 vaccine."  The lot number for bnt162b2 was not provided and will be requested during follow up.
On 7OCT91 pt recvd DTP/HIB mom phoned approx 4-5 hrs later & stated pt rt leg very reddened & tender & appearing swollen for about 1-1.5 " all around leg; pt did not seem self; hardened area on leg;
No additional AE; HCP calling to report that PROQUAD vaccine which expired on April 14, 2022 was administered to a patient today, April 21, 2022. Caller confirms the product was stored appropriately and there were no temperature excursions on the product. No additiona; This spontaneous report was received from a licensed practical nurse and refers to a patient of unspecified age and gender. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were not reported.  On 21-APR-2022, the patient was vaccinated with expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, lot #T035409, expiration date: 14-APR-2022 (dose, site and route of administration were not provided) for prophylaxis (Expired product administered). No additional adverse event information was provided (No adverse event).
painful swollen lymph node in the armpit of the same arm the shot was administered.; painful swollen lymph node in the armpit of the same arm the shot was administered.; painful swollen lymph node in the armpit of the same arm the shot was administered.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 15 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 21May2021 15:00 (Batch/Lot number: unknown) at the age of 15 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: LYMPHADENOPATHY (non-serious), LYMPHADENOPATHY (non-serious) all with onset May2021, outcome "recovering" and all described as "painful swollen lymph node in the armpit of the same arm the shot was administered."  Additional information- The patient did not have any relevant medical history. The patient did not have any allergies to food, medications, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in May2021, the patient experienced a painful swollen lymph node in the armpit of the same arm the shot was administered. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Welt about 2.5 inches in diameter at injection site, raised about .5 inches high; welt is red/pink, warm, and very tender. Soreness started that night of the injection but assumed it was just sore from injection, when I woke up in the morning there was that big welt. The following day I had some fatigue and just felt run-down?nothing real remarkable there. Took some ibuprofen and have iced the area a couple of times. Today (2 days post-vax) it is less tender and seems to have shrunk a little bit but still very present.
Large painful erythematous patch; he was given DEPO MEDROL 40mg and BENADRYL with relief.
felt the effects; low grade fever for Tuesday and some of Wednesday; Sunday and still having sinus like symptoms; mild to moderate headaches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (felt the effects), PYREXIA (low grade fever for Tuesday and some of Wednesday), SINUS DISORDER (Sunday and still having sinus like symptoms) and HEADACHE (mild to moderate headaches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (felt the effects), PYREXIA (low grade fever for Tuesday and some of Wednesday), SINUS DISORDER (Sunday and still having sinus like symptoms) and HEADACHE (mild to moderate headaches). At the time of the report, VACCINATION COMPLICATION (felt the effects), PYREXIA (low grade fever for Tuesday and some of Wednesday), SINUS DISORDER (Sunday and still having sinus like symptoms) and HEADACHE (mild to moderate headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient took booster shot last Monday afternoon and felt the effects including low grade fever for Tuesday band some of Wednesday. It is Sunday and still having sinus like symptoms along with mild to moderate headaches.  Concomitant medication use was not provided Treatment information was not provided,
Received Td vaccine at approximately 18:30 06/19/2003.  That evening started having soreness in left shoulder-extending up into neck.  By next day had numbness in face and tongue.  Left side of face.  Saw MD-Diagnosis: Bells Palsy on prednisone 25mg.
Fever; Itching all over body; Bruising at injection site; Body aches; This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 82-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th April 2019, the patient received Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced fever, generalized pruritus, injection site bruising and general body pain. On an unknown date, the outcome of the fever, generalized pruritus, injection site bruising and general body pain were recovered/resolved.   It was unknown if the reporter considered the fever, generalized pruritus, injection site bruising and general body pain to be related to Shingrix.  Additional details were reported as follows: Adverse reaction to Shingrix vaccine fever, itch all over for 17 days post vaccinatioin, also a large bruise at injection site for 17 days post vaccination and body aches.
Two weeks after the TDAP vaccine was administered I woke up with pins and needles sensation, loss of balance and muscle weakness. I was admitted to the ER and was admitted to the hospital for 10 days. I was then transferred to an inpatient rehab hospital for another 17 days. I had paralysis in my legs up to my shoulders. I was treated with Immunoglobulin for 5 days. After I went home I continued outpatient physical and occupational therapy for about 6 months. To this day I still have fatigue, muscle weakness and benign fasciculation in both legs.
High fever- 102, chills, extremely bad headache, body aches, some stomach pain, and a sore arm. I had the same reaction to the first vaccine 7/14/22.
serious coughing spell; couldn't catch her breath; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (serious coughing spell) and DYSPNOEA (couldn't catch her breath) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (serious coughing spell) and DYSPNOEA (couldn't catch her breath). At the time of the report, COUGH (serious coughing spell) and DYSPNOEA (couldn't catch her breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was sent for an X-ray. Concomitant product information was not provided. Treatment information was not provided by the reporter.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Additional information received and contains non significant information
5 day after receiving MMR/Varicella/ Hep A patient developed vesicular rash over lower extremities and few on upper extremities.
On 10/25/99, had flu-like aches, all night. On 10/27/99, much sneezing & severe sore throat. On 10/28/99, had nasal stuffiness symptoms, same for a week, bronchial congestion.
patient states she had pain immediately following vaccine which radiated to bilateral shoulders into posterior neck into posterior head and left side of face pain and tingling. Pt. has been taking tylenol every 6 hours since reaction. Pt. states that she has been in contact with her pcp who told her to continue to take tylenol. 230 am pt 1/14/21 woke up with nausea, throat burning, bilateral ear burning sensation and redness. Pt. took 4 mg zofran and 25 mg benadryl . Patient states that when she woke back up at 830 am her nausea, throat burning, bilateral burning sensation and redness to ears resolved. Pt. states that her bilateral shoulders, posterior neck, posterior head, and left side of face is still tingling .
An expired Covid-19 pfizer vaccine was administered to the patient on 4/18/22.  The vaccine expired on 4/18/22 at 10am.  The error was discovered on 4/29/22. On 5/3, a COVID-19 Vaccine temperature related enquiry form was filled out and emailed to Pfizer.  On 5-9-22 at 7:51am, we received an email from Pfizer's quality team stating they do not have stability data to support our excursion from prescribed storage conditions. We have reached out to our affected patients informing them of the situation and offered to revaccinate them if they choose to. Left messages on 5-9,5-10, and 5-11 for patient to call pharmacy back.
Received vaccines 1230AM - Broke out in welts and mother called 311pm - BENADRYL given. Seen by Doctor 410pm.
Vaccine received 3/7/03 (#2 in series). 4/16/03 Reports rash on opposite arm of vaccination; shoulder to elbow. 6/8/04 Patient reports rash kept spreading; hair loss. Went to doctor July or August and diagnosed with autoimmune disorder; dermatomyositis. Losing muscle mass. Doctor thinks vaccine could be the cause.   As per annual follow up report: continues to have painful skin lesions and muscle deterioration.
Tightness, heat, pain in chest radiating out to armpits and arms.  Lasted about 2 months.  Also developed jaundice, fatigue and headache.
Itchiness on the injection site; Soreness on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness on the injection site) and VACCINATION SITE PAIN (Soreness on the injection site) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness on the injection site) and VACCINATION SITE PAIN (Soreness on the injection site). At the time of the report, VACCINATION SITE PRURITUS (Itchiness on the injection site) and VACCINATION SITE PAIN (Soreness on the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
The pt was taken to health services on 4/26/01 at 8:00 am. The pt was unresponsive, not breathing, blood at nose. ACL protocol started immediately. No rhythm or pulse. Code stopped. Autopsy report states cause of death: changes suggestive of vaccine related death, however, rollover cannot be excluded and would have to be excluded by scene investigation; findings are not consistent with SIDS.
Dizzy, blur vision, HA observed 45mins.  1/13/21 6 lb weight gain. Hx of autoimmune dz.
Date and time of vaccination: (list both if they received both shots): 1st: 1/21/2021 @ 0900, 2nd: 2/13/2021 @ 0900 Brand and lot of vaccine: Pfizer 1st: el8982, 2nd: el9269 Right arm pain described as intermittent sharp pain from shoulder to wrist as well as pain at injection site. Denies any erythema or swelling. Denies any chest pain or shortness of breath. Not taking any medications for pain. Admits to known "nerve pain" in right arm from several years ago.
Pt vax /w Engerix B immediately c/o pain in deltoid, /win 5 min pain extended from tips of fingers to top of shoulder & /win 1/2 hr pain through chest & groin.
CHILLS FOLLOWED BY HEADACHE THEN FEVER OF 101.7F STARTING AT 10PM  ON 1/25/2021 (5 HOURS AFTER INJECTION)  AND STILL CONTINUING AT TIME OF THIS SUBMISSION ~4PM ON 1/26/2021. SYMPTOMS PARTIALLY RELIEVED BY 500MG ACETOMENOPHNE
Starting approximately one week after the first dose of the Moderna vaccine, I started developing gastrointestinal symptoms. Over the course of the past two months, I have not been able to eat a normal diet and have needed to restrict to plain carbohydrates, some meats, and cooked vegetables. I have experienced frequent diarrhea (at least once a day), though the likelihood decreases if I stick to a plain diet. This has lasted for over two months.  My provider is considering diagnosing me with Irritable Bowel Syndrome. I have not had such symptoms prior to the week following my first vaccination dose; these appeared suddenly and have not remitted since. These symptoms are accompanied by fatigue, loss of appetite, and unintended weight loss. These are causing me significant impairment.  Note that I also experienced a vasovagal episode when I received my first dose of the vaccine, though recovered within the day.   To test the possibility that these symptoms are the result of anxiety given my history, I have increased my antidepressant medication dosage. When my GI symptoms suddenly started in early February, I did have a concurrent increase in anxiety/panic. However, my psychological symptoms have since then remitted, but my GI symptoms never did. I also have never experienced the level of GI problems, as well as specific dietary restrictions, due only to anxiety in my lifetime.
Per students mother "student had been having facial tics 6 mos before receiving H1N1 vaccine on 11/5/2009 48-72 hours after shot received has increased facial tics eyes involuntarily raised up and looked off to left.  Seen by pediatrician EEG done. To see neurologist 12/21/09.  12/7/09:  Primary care records received for date of service 11/7/09. Presents with facial tics and eyes rolling to side, episodes last for up to 10 minutes.  Referral made and EEG scheduled.
Immediate loss of consciousness.  I lost color in my face (pale white) I experienced chills and cold. My hands were shaking for about 4 hours following. From the fall, I developed right shoulder pain, right hip pain, jaw pain, right eye pain, right chest pain,  right back pain, and a black eye.  All symptoms have lasted a week.A I also had fever for about a day, along with generally feeling weak/unwell.A  I
Mild fever within 1 week change in cognitive abilities & behavior. Within 1st 24-48 hours rash over upper forequarter resolved within 2 more days (No rash prior 3 DTP) 1-2 weeks x continued with self destructive behavior temper tantrum, autism spectrum disorder, hyperactivity post encephalitis, altered cognitive abilities, no longer counts (did count 1-15).  6/9/09 Medical records DOS 7/10/06 to 3/10/09. Post vaccination: cognitive ability decreased, temper tantrums, head banging. Behavioral evaluation: Significant developmental delay, restlesness, avoids eye contact, hurts himself on purpose. Difficulty with compliance.
Pt says it hurts to move her arm. It is sore later came to report she could not lift arm above her head.
Information has been received from a health professional concerning a 13 month old male patient with no drug reactions or allergies who on 16-SEP-2010 was vaccinated with a dose of PROQUAD (Merck). There was no concomitant medication. On 24-SEP-2010, the patient developed redness at the injection site and a 1.5 inch circular papulovascular rash. The patient's outcome was not reported. Patient sought medical attention by a visit to the office. Additional information has been requested.
On my right foot I got Herpes soster, intense pain in the muscles, burning and itching, balls with water, the treatment that the doctor gave me was the same to treat shingles.
DVT in right calf; This is a spontaneous report from a contactable pharmacist (patient). A non-pregnant 53-year-old female patient received bnt162b2, via an unspecified route of administration, administered in Left arm on 21Apr2021 14:30 (Lot Number: EWO170) as 1st dose, single for covid-19 immunization. Medical history included hypertonic bladder. The patient's concomitant medication included unspecified medication. The patient experienced DVT in right calf on 26Apr2021. The event resulted in Emergency room/department or urgent care. The patient received the Xarelto 15mg as treatment. The patient was not pregnant at time of vaccination. The outcome of the event was recovering.; Sender's Comments: The event DVT was considered related to suspect drug BNT162B2 based on compatible temporal association and known safety profile of the drug. however, the contribution of age and underlying medical conditions cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Left upper arm red, raised, warm to touch, about 3 inches across began 14 days after immunization
experience itchy arms; experience sore arm; This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (experience itchy arms) and PAIN IN EXTREMITY (experience sore arm) in a 62-year-old female patient who received mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. A57143B) for COVID-19 vaccination.     The patient was never tested positive for COVID-19.  The patient did not receive any other vaccine given within 1 month prior to Moderna COVID-19 vaccine.  Concurrent medical conditions included Penicillin allergy and Meningitis (had the condition for 15 years) since 2007.    On 07-Sep-2022, the patient received fourth dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 08-Sep-2022, the patient experienced PRURITUS (experience itchy arms) and PAIN IN EXTREMITY (experience sore arm). At the time of the report, PRURITUS (experience itchy arms) and PAIN IN EXTREMITY (experience sore arm) had not resolved.            No concomitant medications were reported.   The patient received Moderna vaccine dose 1 on 27-Jan-2021 (Batch lot no. 007M20A), dose 2 on 24-Feb-2021 (Batch lot no. 002A2) and dose 3 (1st booster dose) on 18-Nov-2021 (Batch lot no. 048F21A).  It was reported that, the patient experienced sore and itchy arm after getting the booster dose. The patient did not seek medical help yet for side effects. The patient did not experience similar events in the past.  No treatment details were reported.   This case was linked to MOD-2022-644010 (Patient Link).
swollen lips and tongue about 2 and 1/2 hours after recieving  2nd dose of covid vaccination